InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by DRISCOLL FREDERICK W, Chief Financial Officer. Insider active across 2 companies, notably Flexion Therapeutics Inc. Aggregated, 6 filings have been published. Total volume traded: €34k. The latest transaction was filed on 19 November 2021 — Disposition. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€229,39030,680 shares@ €7.4769100.0% of flow
Common Stock
SEC:0001209191-21-065705·
€229,39030,680 shares@ €7.476950.0% of flow
Common Stock
SEC:0001209191-21-065705:0·
€17,04619,417 shares@ €0.8779100.0% of flow
Common Stock
SEC:0001104659-21-113416·
Ideal exit: 31 May 2022 (T+270)
€17,04619,417 shares@ €0.87790.14% mcap50.0% of flow
Common Stock
SEC:0001104659-21-113416:0·
Ideal exit: 31 May 2022 (T+270)
028,000 shares0
Common Stock
SEC:0001209191-21-037641·
028,000 shares0
Common Stock
SEC:0001209191-21-037641:0·
6 of 6 declarations
About DRISCOLL FREDERICK W
DRISCOLL FREDERICK W is the Chief Financial Officer and Board Member at Flexion Therapeutics Inc and Cellectar Biosciences, Inc. He oversees the financial functions of the companies, ensuring compliance and financial performance. His role is crucial for financial strategy.
